Experimental approaches to modeling delirium in zebrafish (Danio rerio)

Abstract

Delirium is an acute psychiatric syndrome characterized by impaired attention, perception and orientation in space. Albeit known for millennia, the mechanisms and risk factors of delirium remain poorly understood. Experimental animal models, especially rodents, become widely used to understand these pathogenetic aspects. However, a new model organism — zebrafish (Danio rerio) also has promise in this field. Discussed here, recent behavioral tests and protocols for zebrafish enable assessing their behavioral and cognitive function, and its experimental modulation by deliriant drugs and other factors.

Keywords

zebrafish / delirium / experimental models

References

[1] Sachdev PS, Blacker D, Blazer DG, et al. Classifying neurocognitive disorders: the DSM-5 approach. Nat Rev Neurol. 2014;10(11): 634–642. DOI: 10.1038/nrneurol.2014.181

[2] Sachdev P.S., Blacker D., Blazer D.G., et al. Classifying neurocognitive disorders: the DSM-5 approach // Nat Rev Neurol. 2014. Vol. 10, No. 11. P. 634–642. DOI: 10.1038/nrneurol.2014.181

[3] Inouye SK, Westendorp RG, Saczynski JS. Delirium in elderly people. Lancet. 2014;383(9920):911–922. DOI: 10.1016/S0140-6736(13)60688-1

[4] Inouye S.K., Westendorp R.G., Saczynski J.S. Delirium in elderly people // Lancet. 2014. Vol. 383, No. 9920. P. 911–922. DOI: 10.1016/S0140-6736(13)60688-1

[5] van den Boogaard M, Slooter AJC. Delirium in critically ill patients: current knowledge and future perspectives. BJA Educ. 2019;19(12):398–404. DOI: 10.1016/j.bjae.2019.09.004

[6] van den Boogaard M., Slooter A.J.C. Delirium in critically ill patients: current knowledge and future perspectives // BJA Educ. 2019. Vol. 19, No. 12. P. 398–404. DOI: 10.1016/j.bjae.2019.09.004

[7] European Delirium Associations, American Delirium Society. The DSM-5 criteria, level of arousal and delirium diagnosis: inclusiveness is safer. BMC Med. 2014;12:141. DOI: 10.1186/s12916-014-0141-2

[8] European Delirium Associations, American Delirium Society. The DSM-5 criteria, level of arousal and delirium diagnosis: inclusiveness is safer // BMC Med. 2014. Vol. 12. ID 141. DOI: 10.1186/s12916-014-0141-2

[9] Maldonado JR. Neuropathogenesis of delirium: review of current etiologic theories and common pathways. Am J Geriatr Psychiatry. 2013;21(12):1190–1222. DOI: 10.1016/j.jagp.2013.09.005

[10] Maldonado J.R. Neuropathogenesis of delirium: review of current etiologic theories and common pathways // Am J Geriatr Psychiatry. 2013. Vol. 21, No. 12. P. 1190–1222. DOI: 10.1016/j.jagp.2013.09.005

[11] Pereverzev AP, Ostroumova OD, Isaev RI, et al. Drug-induced delirium in elderly and senile patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(7):120–127. (In Russ.). DOI: 10.17116/jnevro2019119071120

[12] Переверзев А.П., Остроумова О.Д., Исаев Р.И., и др. Лекарственно-индуцированный делирий у пациентов пожилого и старческого возраста // Журнал неврологии и психиатрии им. С.С. Корсакова. 2019. Т. 119, № 7. С. 120–127. DOI: 10.17116/jnevro2019119071120

[13] Setters B, Solberg LM. Delirium. Prim Care. 2017;44(3):541–559. DOI: 10.1016/j.pop.2017.04.010

[14] Setters B., Solberg L.M. Delirium // Prim Care. 2017. Vol. 44, No. 3. P. 541–559. DOI: 10.1016/j.pop.2017.04.010

[15] Adamis D, Treloar A, Martin FC, Macdonald AJ. A brief review of the history of delirium as a mental disorder. Hist Psychiatry. 2007;18(72 Pt 4):459–469. DOI: 10.1177/0957154X07076467

[16] Adamis D., Treloar A., Martin F.C., Macdonald A.J. A brief review of the history of delirium as a mental disorder // Hist Psychiatry. 2007. Vol. 18, No. 72 Pt 4. P. 459–469. DOI: 10.1177/0957154X07076467

[17] Trzepacz PT, Leavitt M, Ciongoli K. An animal model for delirium. Psychosomatics. 1992;33(4):404–415. DOI: 10.1016/S0033-3182(92)71945-8

[18] Trzepacz P.T., Leavitt M., Ciongoli K. An animal model for delirium // Psychosomatics. 1992. Vol. 33, No. 4. P. 404–415. DOI: 10.1016/S0033-3182(92)71945-8

[19] Velagapudi R, Subramaniyan S, Xiong C, et al. Orthopedic surgery triggers attention deficits in a delirium-like mouse model. Front Immunol. 2019;10:2675. DOI: 10.3389/fimmu.2019.02675

[20] Velagapudi R., Subramaniyan S., Xiong C., et al. Orthopedic Surgery Triggers Attention Deficits in a Delirium-Like Mouse Model // Front Immunol. 2019. Vol. 10. ID 2675. DOI: 10.3389/fimmu.2019.02675

[21] Viana J, Wildman N, Hannon E, et al. Clozapine-induced transcriptional changes in the zebrafish brain. NPJ Schizophr. 2020;6:3. DOI: 10.1038/s41537-019-0092-x

[22] Viana J., Wildman N., Hannon E., et al. Clozapine-induced transcriptional changes in the zebrafish brain // NPJ Schizophr. 2020. Vol. 6. ID 3. DOI: 10.1038/s41537-019-0092-x

[23] Wang G, Zhang G, Li Z, et al. Abnormal behavior of zebrafish mutant in dopamine transporter is rescued by clozapine. iScience. 2019;17:325–333. DOI: 10.1016/j.isci.2019.06.039

[24] Wang G., Zhang G., Li Z., et al. Abnormal behavior of zebrafish mutant in dopamine transporter is rescued by clozapine // iScience. 2019. Vol. 17. P. 325–333. DOI: 10.1016/j.isci.2019.06.039

[25] Bruni G, Rennekamp AJ, Velenich A, et al. Zebrafish behavioral profiling identifies multitarget antipsychotic-like compounds. Nat Chem Biol. 2016;12(7):559–566. DOI: 10.1038/nchembio.2097

[26] Bruni G., Rennekamp A.J., Velenich A., et al. Zebrafish behavioral profiling identifies multitarget antipsychotic-like compounds // Nat Chem Biol. 2016. Vol. 12, No. 7. P. 559–566. DOI: 10.1038/nchembio.2097

[27] Giacomini NJ, Rose B, Kobayashi K, Guo S. Antipsychotics produce locomotor impairment in larval zebrafish. Neurotoxicol Teratol. 2006;28(2):245–250. DOI: 10.1016/j.ntt.2006.01.013

[28] Giacomini N.J., Rose B., Kobayashi K., Guo S. Antipsychotics produce locomotor impairment in larval zebrafish // Neurotoxicol Teratol. 2006. Vol. 28, No. 2. P. 245–250. DOI: 10.1016/j.ntt.2006.01.013

[29] Sivalingam M, Ogawa S, Parhar IS. Habenula kisspeptin retrieves morphine impaired fear memory in zebrafish. Sci Rep. 2020;10:19569. DOI: 10.1038/s41598-020-76287-9

[30] Sivalingam M., Ogawa S., Parhar I.S. Habenula kisspeptin retrieves morphine impaired fear memory in zebrafish // Sci Rep. 2020. Vol. 10. ID 19569. DOI: 10.1038/s41598-020-76287-9

[31] Volgin AD, Yakovlev OA, Demin KA, et al. Acute behavioral effects of deliriant hallucinogens atropine and scopolamine in adult zebrafish. Behav Brain Res. 2019;359:274–280. DOI: 10.1016/j.bbr.2018.10.033

[32] Volgin A.D., Yakovlev O.A., Demin K.A., et al. Acute behavioral effects of deliriant hallucinogens atropine and scopolamine in adult zebrafish // Behav Brain Res. 2019. Vol. 359. P. 274–280. DOI: 10.1016/j.bbr.2018.10.033

[33] Chen F, Chen S, Liu S, et al. Effects of lorazepam and WAY-200070 in larval zebrafish light/dark choice test. Neuropharmacology. 2015;95:226–233. DOI: 10.1016/j.neuropharm.2015.03.022

[34] Chen F., Chen S., Liu S., et al. Effects of lorazepam and WAY-200070 in larval zebrafish light/dark choice test // Neuropharmacology. 2015. Vol. 95. P. 226–233. DOI: 10.1016/j.neuropharm.2015.03.022

[35] da Silva Chaves SN, Felicio GR, Costa BPD, et al. Behavioral and biochemical effects of ethanol withdrawal in zebrafish. Pharmacol Biochem Behav. 2018;169:48–58. DOI: 10.1016/j.pbb.2018.04.006

[36] da Silva Chaves S.N., Felicio G.R., Costa B.P.D., et al. Behavioral and biochemical effects of ethanol withdrawal in zebrafish // Pharmacol Biochem Behav. 2018. Vol. 169. P. 48–58. DOI: 10.1016/j.pbb.2018.04.006

[37] Krook JT, Duperreault E, Newton D, et al. Repeated ethanol exposure increases anxiety-like behaviour in zebrafish during withdrawal. PeerJ. 2019;7: e6551. DOI: 10.7717/peerj.6551

[38] Krook J.T., Duperreault E., Newton D., et al. Repeated ethanol exposure increases anxiety-like behaviour in zebrafish during withdrawal // PeerJ. 2019. Vol. 7. ID e6551. DOI: 10.7717/peerj.6551

[39] Khor B-S, Amar Jamil MF, Adenan MI, Shu-Chien AC. Mitragynine attenuates withdrawal syndrome in morphine-withdrawn zebrafish. PLoS One. 2011;6(12): e28340. DOI: 10.1371/journal.pone.0028340

[40] Khor B.-S., Amar Jamil M.F., Adenan M.I., Shu-Chien A.C. Mitragynine attenuates withdrawal syndrome in morphine-withdrawn zebrafish // PLoS One. 2011. Vol. 6, No. 12. ID e28340. DOI: 10.1371/journal.pone.0028340

[41] Cachat J, Canavello P, Elegante M, et al. Modeling withdrawal syndrome in zebrafish. Behav Brain Res. 2010;208(2):371–376. DOI: 10.1016/j.bbr.2009.12.004

[42] Cachat J., Canavello P., Elegante M., et al. Modeling withdrawal syndrome in zebrafish // Behav Brain Res. 2010. Vol. 208, No. 2. P. 371–376. DOI: 10.1016/j.bbr.2009.12.004

[43] Kim Y-H, Lee Y, Kim D, et al. Scopolamine-induced learning impairment reversed by physostigmine in zebrafish. Neurosci Res. 2010;67(2):156–161. DOI: 10.1016/j.neures.2010.03.003

[44] Kim Y.-H., Lee Y., Kim D., et al. Scopolamine-induced learning impairment reversed by physostigmine in zebrafish // Neurosci Res. 2010. Vol. 67, No. 2. P. 156–161. DOI: 10.1016/j.neures.2010.03.003

[45] Franscescon F, Muller TE, Bertoncello KT, Rosemberg DB. Neuroprotective role of taurine on MK-801-induced memory impairment and hyperlocomotion in zebrafish. Neurochem Int. 2020;135:104710. DOI: 10.1016/j.neuint.2020.104710

[46] Franscescon F., Muller T.E., Bertoncello K.T., Rosemberg D.B. Neuroprotective role of taurine on MK-801-induced memory impairment and hyperlocomotion in zebrafish // Neurochem Int. 2020. Vol. 135. ID 104710. DOI: 10.1016/j.neuint.2020.104710

[47] Zakhary SM, Ayubcha D, Ansari F, et al. A behavioral and molecular analysis of ketamine in zebrafish. Synapse. 2011;65(2):160–167. DOI: 10.1002/syn.20830

[48] Zakhary S.M., Ayubcha D., Ansari F., et al. A behavioral and molecular analysis of ketamine in zebrafish // Synapse. 2011. Vol. 65, No. 2. P. 160–167. DOI: 10.1002/syn.20830

[49] Flaherty JH, Yue J, Rudolph JL. Dissecting delirium: phenotypes, consequences, screening, diagnosis, prevention, treatment, and program implementation. Clin Geriatr Med. 2017;33(3):393–413. DOI: 10.1016/j.cger.2017.03.004

[50] Flaherty J.H., Yue J., Rudolph J.L. Dissecting delirium: phenotypes, consequences, screening, diagnosis, prevention, treatment, and program implementation // Clin Geriatr Med. 2017. Vol. 33, No. 3. P. 393–413. DOI: 10.1016/j.cger.2017.03.004

[51] Gaertner J, Eychmueller S, Leyhe T, et al. Benzodiazepines and/or neuroleptics for the treatment of delirium in palliative care? — a critical appraisal of recent randomized controlled trials. Ann Palliat Med. 2019;8(4):504–515. DOI: 10.21037/apm.2019.03.06

[52] Gaertner J., Eychmueller S., Leyhe T., et al. Benzodiazepines and/or neuroleptics for the treatment of delirium in palliative care? — a critical appraisal of recent randomized controlled trials // Ann Palliat Med. 2019. Vol. 8, No. 4. P. 504–515. DOI: 10.21037/apm.2019.03.06

[53] Inouye SK. Delirium in older persons. N Engl J Med. 2006;354:1157–1165. DOI: 10.1056/NEJMra052321

[54] Inouye S.K. Delirium in older persons // N Engl J Med. 2006. Vol. 354. P. 1157–1165. DOI: 10.1056/NEJMra052321

[55] van der Mast RC. Pathophysiology of delirium. J Geriatr Psychiatry Neurol. 1998;11(3):138–145. DOI: 10.1177/089198879801100304

[56] van der Mast R.C. Pathophysiology of delirium // J Geriatr Psychiatry Neurol. 1998. Vol. 11, No. 3. P. 138–145; discussion 57–8. DOI: 10.1177/089198879801100304

[57] Trzepacz PT. The neuropathogenesis of delirium. A need to focus our research. Psychosomatics. 1994;35(4):374–391. DOI: 10.1016/S0033-3182(94)71759-X

[58] Trzepacz P.T. The neuropathogenesis of delirium. A need to focus our research // Psychosomatics. 1994. Vol. 35, No. 4. P. 374–391. DOI: 10.1016/S0033-3182(94)71759-X

[59] Maldonado JR. Delirium in the acute care setting: characteristics, diagnosis and treatment. Crit Care Clin. 2008;24(4):657–722. DOI: 10.1016/j.ccc.2008.05.008

[60] Maldonado J.R. Delirium in the acute care setting: characteristics, diagnosis and treatment // Crit Care Clin. 2008. Vol. 24, No. 4. P. 657–722. DOI: 10.1016/j.ccc.2008.05.008

RIGHTS & PERMISSIONS

Maslov G.O., Kolesnikova T.O., Zabegalov K.N., Kalueff A.V.